Therapeutic potential of human induced pluripotent stem cell-derived mesenchymal stem cells in mice with lethal fulminant hepatic failure

Cell Transplantation

Volumn 22, Issue 10, 2013, Pages 1785-1799

  Moslem, Mohsen ^a   Valojerdi, Mojtaba Rezazadeh ^a   Pournasr, Behshad ^b   Muhammadnejad, Ahad ^c   Baharvand, Hossein ^b,d  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF SCIENCE AND CULTURE   (Iran)

Author keywords

Fulminant hepatic failure (FHF); Human induced pluripotent stem cells (hiPSCs); Mesenchymal stem cells (MSCs)

Indexed keywords

BILIRUBIN; CARBON TETRACHLORIDE; COLLAGEN TYPE 1; COLLAGENASE 3; GELATINASE A; GELATINASE B; LACTATE DEHYDROGENASE; LIPID; SCATTER FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILIRUBIN BLOOD LEVEL; BONE MARROW; CELL COUNT; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE RELEASE; FULMINANT HEPATIC FAILURE; GENE EXPRESSION; IN VITRO STUDY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPID PEROXIDATION; LIVER CELL; LIVER FUNCTION; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; MOUSE MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SURVIVAL; THERAPY EFFECT; TISSUE SECTION;

ANIMALS; BILIRUBIN; CELLS, CULTURED; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; HEPATOCYTE GROWTH FACTOR; HUMANS; INDUCED PLURIPOTENT STEM CELLS; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; LIVER; LIVER FAILURE, ACUTE; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84884697664     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X662462     Document Type: Article

References (48)

1. Aurich, H.; Sgodda, M.; Kaltwasser, P.; Vetter, M.; Weise, A.; Liehr, T.; Brulport, M.; Hengstler, J. G.; Dollinger, M. M.; Fleig, W. E. Christ, B. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut 58(4):570-581; 2009.
2. Aurich, I.; Mueller, L. P.; Aurich, H.; Luetzkendorf, J.; Tisljar, K.; Dollinger, M. M.; Schormann, W.; Walldorf, J.; Hengstler, J. G.; Fleig, W. E.; Christ, B. Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut 56(3):405-415; 2007.
3. Banas, A.; Teratani, T.; Yamamoto, Y.; Tokuhara, M.; Takeshita, F.; Osaki, M.; Kato, T.; Okochi, H.; Ochiya, T. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J. Gastroenterol. Hepatol. 24(1):70-77; 2009.
4. Barberi, T.; Willis, L. M.; Socci, N. D.; Studer, L. Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med. 2(6):e161; 2005.
5. Bernal, W.; Auzinger, G.; Dhawan, A.; Wendon, J. Acute liver failure. Lancet 376(9736):190-201; 2010.
6. Giuliani, M.; Oudrhiri, N.; Noman, Z. M.; Vernochet, A.; Chouaib, S.; Azzarone, B.; Durrbach, A.; Bennaceur-Griscelli, A. Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery. Blood 118(12):3254-3262; 2011.
7. Gomez-Aristizabal, A.; Keating, A.; Davies, J. E. Mesenchymal stromal cells as supportive cells for hepatocytes. Mol. Ther. 17(9):1504-1508; 2009.
8. Gonzalez, F.; Boue, S.; Belmonte, J. C. Methods for making induced pluripotent stem cells: Reprogramming a la carte. Nat. Rev. Genet. 12(4):231-242; 2011.
9. Gruenloh, W.; Kambal, A.; Sondergaard, C.; McGee, J.; Nacey, C.; Kalomoiris, S.; Pepper, K.; Olson, S.; Fierro, F.; Nolta, J. A. Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cells. Tissue Eng. Part A 17(11-12):1517-1525; 2011.
10. Hematti, P. Human embryonic stem cell-derived mesenchymal progenitors: An overview. Methods Mol. Biol. 690:163-174; 2011.
11. Hu, J. J.; Sun, C.; Lan, L.; Chen, Y. W.; Li, D. G. Therapeutic effect of transplanting e(2)m(-)/Thy1(+) bone marrowderived hepatocyte stem cells transduced with lentiviralmediated HGF gene into CCl(4)-injured rats. J. Gene Med. 12(3):244-254; 2010.
12. Hwang, N. S.; Varghese, S.; Lee, H. J.; Zhang, Z.; Ye, Z.; Bae, J.; Cheng, L.; Elisseeff, J. In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc. Natl. Acad. Sci. USA 105(52):20641-20646; 2008.
13. Jung, Y.; Bauer, G.; Nolta, J. A. Induced pluripotent stem cell-derived mesenchymal stem cells: Progress toward safe clinical products. Stem Cells 30(1):42-47; 2012.
14. Kasper, G.; Mao, L.; Geissler, S.; Draycheva, A.; Trippens, J.; Kuhnisch, J.; Tschirschmann, M.; Kaspar, K.; Perka, C.; Duda, G. N.; Klose J. Insights into mesenchymal stem cell aging: Involvement of antioxidant defense and actin cytoskeleton. Stem Cells 27(6):1288-1297; 2009.
15. Knodell, R. G.; Ishak, K. G.; Black, W. C.; Chen, T. S.; Craig, R.; Kaplowitz, N.; Kiernan, T. W.; Wollman, J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1(5):431-435; 1981.
16. Kuo, T. K.; Hung, S. P.; Chuang, C. H.; Chen, C. T.; Shih, Y. R.; Fang, S. C.; Yang, V. W.; Lee, O. K. Stem cell therapy for liver disease: Parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 134(7):2111-2121; 2008.
17. Lat, I.; Foster, D. R.; Erstad, B. Drug-induced acute liver failure and gastrointestinal complications. Crit. Care Med. 38(6 Suppl):S175-S187; 2010.
18. Laurila, J. P.; Laatikainen, L.; Castellone, M. D.; Trivedi, P.; Heikkila, J.; Hinkkanen, A.; Hematti, P.; Laukkanen, M. O. Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model. Cytotherapy 11(6):726-737; 2009.
19. Lee, E. J.; Lee, H. N.; Kang, H. J.; Kim, K. H.; Hur, J.; Cho, H. J.; Lee, J.; Chung, H. M.; Cho, J.; Cho, M. Y.; Oh, S. K.; Moon, S. Y.; Park, Y. B.; Kim, H. S. Novel embryoid body-based method to derive mesenchymal stem cells from human embryonic stem cells. Tissue Eng. Part A 16(2):705-715; 2010.
20. Li, Z.; Mizuno, S.; Nakamura, T. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases. Am. J. Physiol. Gastrointest. Liver Physiol. 292(2):G639-646; 2007.
21. Lian, Q.; Lye, E.; Suan Yeo, K.; Khia Way Tan, E.; Salto-Tellez, M.; Liu, T. M.; Palanisamy, N.; El Oakley, R. M.; Lee, E. H.; Lim, B.; Lim, S. K. Derivation of clinically compliant MSCs from CD105+, CD24-differentiated human ESCs. Stem Cells 25(2):425-436; 2007.
22. Lian, Q.; Zhang, Y.; Zhang, J.; Zhang, H. K.; Wu, X.; Zhang, Y.; Lam, F. F.; Kang, S.; Xia, J. C.; Lai, W. H.; Au, K. W.; Chow, Y. Y.; Siu, C. W.; Lee, C. N.; Tse, H. F. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 121(9):1113-1123; 2010.
23. Mahmood, A.; Harkness, L.; Schroder, H. D.; Abdallah, B. M.; Kassem, M. Enhanced differentiation of human embryonic stem cells to mesenchymal progenitors by inhibition of TGF-T/activin/nodal signaling using SB-431542. J. Bone Miner. Res. 25(6):1216-1233; 2010.
24. Olivier, E. N.; Rybicki, A. C.; Bouhassira, E. E. Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. Stem Cells 24(8):1914-1922; 2006.
25. Pakzad, M.; Totonchi, M.; Taei, A.; Seifinejad, A.; Hassani, S. N.; Baharvand, H. Presence of a ROCK inhibitor in extracellular matrix supports more undifferentiated growth of feeder-free human embryonic and induced pluripotent stem cells upon passaging. Stem Cell Rev. 6(1):96-107; 2010.
26. Parekkadan, B.; van Poll, D.; Suganuma, K.; Carter, E. A.; Berthiaume, F.; Tilles, A. W.; Yarmush, M. L. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One 2(9):e941; 2007.
27. Petersen, B. E.; Bowen, W. C.; Patrene, K. D.; Mars, W. M.; Sullivan, A. K.; Murase, N.; Boggs, S. S.; Greenberger, J. S.; Goff, J. P. Bone marrow as a potential source of hepatic oval cells. Science 284(5417):1168-1170; 1999.
28. Philonenko, E. S.; Shutova, M. V.; Chestkov, I. V.; Lagarkova, M. A.; Kiselev, S. L. Current progress and potential practical application for human pluripotent stem cells. Int. Rev. Cell. Mol. Biol. 292:153-196; 2011.
29. Plath, K.; Lowry, W. E. Progress in understanding reprogramming to the induced pluripotent state. Nat. Rev. Genet. 12(4):253-265; 2011.
30. Roobrouck, V. D.; Ulloa-Montoya, F.; Verfaillie, C. M. Self-renewal and differentiation capacity of young and aged stem cells. Exp. Cell Res. 314(9):1937-1944; 2008.
31. Sahreen, S.; Khan, M. R.; Khan, R. A. Hepatoprotective effects of methanol extract of Carissa opaca leaves on CCl4-induced damage in rat. BMC Complement Altern. Med. 11:48; 2011.
32. Sanchez, L.; Gutierrez-Aranda, I.; Ligero, G.; Rubio, R.; Munoz-Lopez, M.; Garcia-Perez, J. L.; Ramos, V.; Real, P. J.; Bueno, C.; Rodriguez, R.; Delgado, M.; Menendez, P. Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease. Stem Cells 29(2):251-262; 2011.
33. Sharma, A. D.; Cantz, T.; Richter, R.; Eckert, K.; Henschler, R.; Wilkens, L.; Jochheim-Richter, A.; Arseniev, L.; Ott, M. Human cord blood stem cells generate human cytokeratin 18-negative hepatocyte-like cells in injured mouse liver. Am. J. Pathol. 167(2):555-564; 2005.
34. Simpson, D. L.; Boyd, N. L.; Kaushal, S.; Stice, S. L.; Dudley, Jr., S. C. Use of human embryonic stem cell derived-mesenchymal cells for cardiac repair. Biotechnol. Bioeng. 109(1):274-283; 2012.
35. Su, Z.; Wu, R.; Tan, Z.; Li, Y.; Chen, L.; Luo, J.; Zhang, M. Early homing behavior of Stro-1-mesenchyme-like cells derived from human embryonic stem cells in an immunocompetent xenogeneic animal model. Biochem. Biophys. Res. Commun. 394(3):616-622; 2010.
36. Totonchi, M.; Taei, A.; Seifinejad, A.; Tabebordbar, M.; Rassouli, H.; Farrokhi, A.; Gourabi, H.; Aghdami, N.; Hosseini-Salekdeh, G.; Baharvand, H. Feeder-and serumfree establishment and expansion of human induced pluripotent stem cells. Int. J. Dev. Biol. 54(5):877-886; 2010.
37. Touboul, T.; Hannan, N. R.; Corbineau, S.; Martinez, A.; Martinet, C.; Branchereau, S.; Mainot, S.; Strick-Marchand, H.; Pedersen, R.; Di Santo, J.; Weber, A.; Vallier, L. Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology 51(5):1754-1765; 2010.
38. Trivedi, P.; Hematti, P. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp. Hematol. 36(3):350-359; 2008.
39. van Poll, D.; Parekkadan, B.; Cho, C. H.; Berthiaume, F.; Nahmias, Y.; Tilles, A. W.; Yarmush, M. L. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 47(5):1634-1643; 2008.
40. Vosough, M.; Moslem, M.; Pournasr, B.; Baharvand, H. Cell-based therapeutics for liver disorders. Br. Med. Bull. 100:157-72; 2011.
41. Wang, X.; Ge, S.; McNamara, G.; Hao, Q. L.; Crooks, G. M.; Nolta, J. A. Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells. Blood 101(10):4201-4208; 2003.
42. Weber, L. W.; Boll, M.; Stampfl, A. Hepatotoxicity and mechanism of action of haloalkanes: Carbon tetrachloride as a toxicological model. Crit. Rev. Toxicol. 33(2):105-136; 2003.
43. Wielockx, B.; Lannoy, K.; Shapiro, S. D.; Itoh, T.; Itohara, S.; Vandekerckhove, J.; Libert, C. Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy. Nat. Med. 7(11):1202-1208; 2001.
44. Xu, C.; Jiang, J.; Sottile, V.; McWhir, J.; Lebkowski, J.; Carpenter, M. K. Immortalized fibroblast-like cells derived from human embryonic stem cells support undifferentiated cell growth. Stem Cells 22(6):972-980; 2004.
45. Yamamoto, S.; Nguyen, J. H. TIMP-1/MMP-9 imbalance in brain edema in rats with fulminant hepatic failure. J. Surg. Res. 134(2):307-314; 2006.
46. Yen, B. L.; Chang, C. J.; Liu, K. J.; Chen, Y. C.; Hu, H. I.; Bai, C. H.; Yen, M. L. Brief report-human embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytes. Stem Cells 27(2):451-456; 2009.
47. Yen, M. L.; Hou, C. H.; Peng, K. Y.; Tseng, P. C.; Jiang, S. S.; Shun, C. T.; Chen, Y. C.; Kuo, M. L. Efficient derivation & concise gene expression profiling of human embryonic stem cell-derived mesenchymal progenitors (EMPs). Cell Transplant. 20(10):1529-1545; 2011.
48. Zagoura, D. S.; Roubelakis, M. G.; Bitsika, V.; Trohatou, O.; Pappa, K. I.; Kapelouzou, A.; Antsaklis, A.; Anagnou, N. P. Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure. Gut 61(6):894-906; 2012.